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Introduction
In the 21st century, all countries has encountered with 
the fundamental problem of cancer, which is the third 
cause of death in the world and according to estimates 
of GLOBOCAN, approximately 12.7million new cancer 
cases and 7.6 million cancer deaths occurred in 2008(Jemal 
et al., 2011). It is predicted to increase annual new cases 
from 10 million in 2000 to 15 million in 2020. However, 
the epidemiologic pattern of cancer showed main 
differences between developed and developing countries. 
Almost 60% of all cancer was seen in developing countries 
(Vakili et al., 2014) and incidence and morphology trend 
of cancers is changing in the different countries (Jemal 
et al., 2010; Almasi et al., 2015; Keyghobadi et al., 2015; 
Rafiemanesh et al., 2015a; Rafiemanesh et al., 2015b; 
Razi et al., 2015).
Breast cancer is the most common cancer and the first 
cause of cancer death in women worldwide. In the past 
decade, the most common cancer was cervical cancer 
among women. In 2008, breast cancer took account for 
23% (1380000 cases) of all new cases and 14% (458400 
cases) of all cancer deaths in the world. About half of 
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Abstract
 Background: Breast cancer is the most common cancer and the first cause of cancer death in women worldwide, 
with infiltrating duct carcinoma as the most common morphology. This study aimed to investigate trend of breast 
cancer incidence by age groups and histological changes in Iranian women between 2003 and 2008. Materials and 
Methods: This is analytic study, carried out based on re-analysis of the Cancer Registry Center report of health 
deputy for women’s breast cancer in Iran during a 6-year period (2003-2008). Statistical analysis for incidence 
time trends and morphology change percentage carried out joinpoint regression analysis using the software 
Joinpoint Regression Program. Results: A total of 36,340 cases were reported for Iranian women in the six years. 
Analytical trend showed an increasing incidence trend with significant annual percentage change (APC) of 15.2 
(CI: 11.6 to 18.8). The lowest and highest significant increased trend were related to age groups of 40 to 44 years 
and above 85 years, respectively; with APCs of 13.0 and 25.1, respectively. Of total cases, 78.7% of cases were 
infiltrating duct carcinoma, decreasing from 82.0% in 2003 to 76.6% in 2008, which was significant with an APC 
equal to -1.76 (CI:-2.7 to -0.8). Conclusions: The incidence trend of breast cancer is rising in Iranian women. 
The highest incidence was observed in the age groups 45-65 and 80-85. In conclusion, to reduce breast cancer 
incidence and its burden, preventive and screening programs for breast cancer, especially in young women, are 
recommended in Iran. 
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incidence cases and 60% of mortality occur in developing 
countries. The highest incidence was observed in West 
and North of Europe, Australia, New Zealand, and North 
America (Jemal et al., 2011). Age-Standardized Incidence 
Rate (ASIR) was different from 19.3 per 100,000 in East 
of Africa to 89.9 per 100,000 in West of Africa. Overall, in 
developed countries, ASR was more than 80 per 100,000, 
but in developing countries less than 40 per 100,000. The 
incidence rate of breast cancer is 39 per 100,000 in women 
in the world (Ferlay et al., 2010). The cancer is the most 
common cancer in Iranian women and the incidence rate 
was 24 per 100,000 in 2004 (Mousavi et al., 2009). 
It seems that genetic factors constitute only 5-10% 
of related risk factors to the cancer (Sasco, 2001; Chin et 
al., 2005; Anand et al., 2008) and 90-95 % of other risk 
factors include changing patterns of reproduction, lack of 
physical inactivity, and obesity (Jemal et al., 2011). It is 
expected to raise incidence of cancer cases due to changes 
in individual’s lifestyle and an increase of life expectancy 
(Mousavi et al., 2009).
In many African and Asian countries, the incidence and 
mortality rates of breast cancer are increasing. However, 
increasing awareness of women and screening tests lead 
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to diagnose more cases in the future (Jemal et al., 2011). 
It is expected to rise the cases in the next years because 
of increased life expectancy and changes in lifestyle and 
attitude to the Western lifestyle (Mousavi et al., 2009).
A similar study in Iran showed that the incidence 
is increasing in the age groups 40-44, 45-49 and 55-59 
years, with an average annual increase of 6.2%, 3.5%, and 
5.3%, respectively (Tazhibi et al., 2014). Another study 
in Oman indicated that the highest ASIR was related to 
age groups of 45-54 years and 70-74 years, respectively 
(Mehdi et al., 2014). 
Considering studies performed worldwide, 
INFILTRATING DUCT CARCINOMA is most common 
morphology of the cancer (Li et al., 2003; Chahine et 
al., 2015; Saxena et al., 2005). Studies in Iran reported 
that INFILTRATING DUCT CARCINOMA is also most 
common morphology of the cancer (Li et al., 2003; 
Mousavi et al., 2007; Naghibi et al., 2013). 
There is a population-based cancer registry program in 
Iran. It is possible to detect common cancers and planning 
for control them using the accurate data. Awareness of the 
prevalent morphology can help diagnose and treatment 
of breast cancer cases, and investigate the stages of the 
disease. This study aimed to investigate trend of breast 
cancer incidence by age groups and histological changes 
in Iranian women between 2003and 2008. 
Materials and Methods
Data source
This is analytic study, carried out based on re-analysis 
national registry of cancer (NCR), and Disease Control 
and Prevention (CDC) report of ministry of Health 
and Medical Education in Iran. Deputy for health of 
each university is responsible for health issues of the 
population and all health activities are managed by these 
deputies. All deputies for health have been included in 
the NCR. Registrar would apply the national registration 
software which was developed by CDC. For pathologic 
centers, without software, the cancer records were 
gathered manually. The Cancer Office of CDC should 
provide techniques and funding supports. The data are 
transmitted every 3 months, by electronic file and also 
hard copy of ‘Cancer Registry Data Collection Form’; 
this form is comprised of three parts: part I, regarding 
patient’s identity characteristics in addition to the name 
of biopsy-taker physician, name of hospital, location of 
which the biopsy is taken, clinical diagnosis and date of 
biopsy sent to histological laboratory and demographic 
information of the patients includes race and residence. 
Part II includes the most important findings of patient’s 
clinical history. Part III includes preclinical findings. 
The information includes primary location of tumor, date 
of cancer diagnosis, morphology and histology and its 
behavior and diagnosis method. Physicians fill the form 
of clinical data and the official personnel fill the identity 
and demographic information. Quality control has been 
coordinated in five main areas by Cancer Office of CDC: 
(i) regarding completeness of coverage; (ii) completeness 
of details; (iii) accuracy of data; (iv) accuracy of reports; 
(v) accuracy of interpretation and (vi) repeated cases are 
deleted from national data. Surveillance of pathology is 
based on the cancer record in several selected provinces 
to compare it with the present pathology cancer record 
for a general and complete evaluation and also for 
the accuracy of the collected data. IARC software 
provides a way to identify inaccuracies in data coding. 
Data were collected retrospectively reviewing all new 
women’s breast cancer patients in Cancer Registry 
Center report of health deputy for Iran during a 6-year 
period (2003 - 2008) (Daubisse-Marliac et al., 2011). 
Accordance of The International Classification of 
Diseases for Oncology (ICD-OC: topography with ICD-
OM: morphology) Breast cancer was defined as ICD-O 
C50(AG., 2000). This study investigated all cases of the 
morphology of INFILTRATING DUCT CARCINOMA 
(8500/3), LOBULAR CARCINOMA, NOS (8520/3), 
MEDULLARY CARCINOMA, NOS (8510/3) and 
INTRADUCTAL CARCINOMA, NONINFILTRATING, 
NOS (8500/2).
Statistical analysis
We calculated crude incidence rate (CIR) and the Age-
standardized incidence rate (ASIR) per 100,000 persons. 
We used direct standardized method using world standard 
population(Santos, 1999). To describe incidence and age 
group incidence time trends, we use Age-standardized 
incidence rate (ASIR) and carried out joinpoint regression 
analysis using the software Joinpoint Regression Program, 
Version 4.1.1.1 October 2014 (Jemal et al., 2007). As well 
to evaluate the morphological changes, were obtained the 
percentage allocated for kind of morphological types. So 
to analysis morphology change percentage trends for six 
year, we carried out joinpoint regression analysis using 
the software Joinpoint Regression Program. The analysis 
included logarithmic transformation of the rates, maximum 
number of one joinpoints, and minimum of six years 
between zero joinpoints. All other program parameters 
were set to default values. The test of significance uses a 
Monte Carlo Permutation method (i.e., it finds “the best 
fit” line). joinpoint regression analysis involves fitting a 
series of joined straight lines on a log scale to the trends. 
The aim of the approach is to identify possible joinpoints 
where a significant change in the trend occurs. The final 
model selected was the most parsimonious of these, with 
the estimated annual percent change (APC) based on the 
trend within each segment. In describing trends, the terms 
“significant increase” or “significant decrease” signify 
Results 
A total of 36,340 cases were reported from Iranian 
women. The highest ASIR was seen at 45 to 65 years and 
80 to 85 years, respectively (Figure1). 
Four histological types of, NONINFILTRATING, 
NOS, INTRADUCTAL CARCINOMA, INFILTRATING 
DUCT CARCINOMA, MEDULLARY CARCINOMA, 
NOS, and LOBULAR CARCINOMA included 89.56% 
of all morphologies.
Epidemiologic incidence Trend:
ASIR increased from 15.96 per 100,000 in 2003 
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to 33.21 per 100,000 in 2008. Analytical trend based 
on Joinpoint logarithmic scale showed an increasing 
incidence trend with significant Annual Percentage 
Changes (APC) of 15.15 (CI: 11.6 to18.8) (Table1). 
The trend of incidence was increasing in age groups 
studied. The lowest and highest significant increased 
trend were related to age groups of 40 to 44 years and 
above 85 years, respectively; with APC of 12.95 and 
25.07,respectively (Table2).
Morphologic Trend
Of total cases, 78.71% of cases were INFILTRATING 
DUCT CARCINOMA, 5.37% LOBULAR CARCINOMA, 
NOS, 2.77% MEDULLARY CARCINOMA, NOS, 
and  2 .71% INTRADUCTAL CARCINOMA, 
NONINFILTRATING, NOS. the dedicated percentage 
was not same for four common morphologies. The 
most common morphology (INFILTRATING DUCT 
CARCINOMA) decreased from 81.98% in 2003 to 
Figure 1. Age-Standardized lncidence Rate (ASIR) of 
breast cancers by 5 years age groups in lranian woman 
in lran, 2003-2003
Figure1:	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Table 1. Number of Cases, Crude Incidence Rate 
and Age-standardized Incidence Rates (per 100,000) 
between 2003 to 2008.
 N. CIR ASIR
   2003 3946 12.19 15.96
   2004 4557 13.84 18.24
   2005 5981 17.44 23.16
   2006 6456 18.9 25.06
   2007 6976 20.42 27.15
   2008 8424 24.66 33.21
CIR: crude incidence rate (per 100,000 persons); ASIR: Age-standardized 
incidence rate (per 100,000 persons)
Table 2. Incidence trends of breast cancers by 5 years age groups in Iranian woman in Iran, 2003-2008 
 Full Range (2003-2008) Trend 1 (2003 -2005) Trend 2 (2005-2008)
Age group AAPC 95% CI APC 95% CI AAPC 95% CI
20-24* 17.9 -2.3 to 42.3
25-29* 14.8^ 2.9 to 28.1
30-34* 13.1^ 10.9 to 15.4
35-39* 14.3^ 8.1 to 20.9
40-44* 12.9^ 10.1 to 15.9
45-49* 13.8^ 9.7 to 18.0
50-54* 16.5^ 10.6 to 22.6
55-59* 17.2^ 13.2 to 21.3
60-64* 18.4^ 12.7 to 24.4
65-69* 13.5^ 9.8 to 17.2
70-74* 13.0^ 8.4 to 17.7
75-79** 15.1^ 13.4 to 16.9 22.5^ 0.8 to 48.8 10.5^ 0.2 to 21.8
80-84* 15.7^ 10 to 21.6
85+** 23.8 -0.9 to 54.7 0.6 -94.4 to 1701.9 42.3 -66.4 to 502.2
^APC or AAPC is significantly different from zero at alpha = 0.05; *Final selected model 0 Joinpoint(s);**Final selected model 1 Joinpoint(s)
Table 3. Morphology Trends of Breast Cancers Percentage Allocated to Four Common Morphology in Iranian 
Woman in Iran, 2003-2008
 Frequency (Percent) Percent Trend 2003-2008
Morphology 2003 2004 2005 2006 2007 2008 APC 95% CI
Infiltrating Duct Carcinoma
 3235 3782 4785 5037 5312 6452 -1.8^ -2.7 To -0.8
 -81.98% -82.99% -80% -78.02% -76.15% -76.59%  
Lobular Carcinoma, Nos
 182 218 347 361 385 460 3.6 -1.3 To 8.8
 -4.61% -4.78% -5.80% -5.59% -5.52% -5.46%  
Medullary Carcinoma, Nos
 139 148 155 157 199 209 -6.1 -12.5 To 0.8
 -3.52% -3.25% -2.59% -2.43% -2.85% -2.48%  
Intraductal Carcinoma, Noninfiltrating, Nos
 96 89 133 119 303 243 9.1 -10.6 To 33.2
 -2.43% -1.95% -2.22% -1.84% -4.34% -2.88%
^APC is significantly different from zero at alpha = 0.05
Hosein Rafiemanesh et al
Asian Pacific Journal of Cancer Prevention, Vol 17, 20161396
76.59% in 2008, which was significant with APC equal 
to -1.76 (CI:-2.7to -0.8) (Table3).
Discussion
During 2003 to 2008, 36340 cancer cases were 
reported from Iranian women. The trend of incidence 
rate in patients suffered from breast cancer showed a 
remarkable increase in all age groups. ASIR increased 
from 15.96 per 100,000 in 2003 to 33.21 per 100,000 
in 2008. The result was different from findings of 
other studies (Naghibi et al., 2013). This may be due to 
difference in speed of lifestyle changes, especially in urban 
areas, and exposure to risk factors in various provinces. A 
similar study in China indicated such difference between 
urban and rural regions (Yang et al., 2015). In developed 
countries, AISR was more than 80 per 100,000 and in 
developing countries the rate was less than 40 per 100,000, 
which consistent with our findings. In women in the world 
the incidence rate of breast cancer was 39 per 100,000 
(Ferlay et al., 2010). However, the rate in Iranian women 
was similar to the rate worldwide. Another study on 
urban population in china revealed that ASIR increased 
from 26.53 per 100,000 between 1989 and 1999 to 42.92 
per 100,000 between 2011 and 2012 (Yang et al., 2015), 
similar to our results. 
Genetic factors include only 5 to 10% of related risk 
factors of breast cancer (Sasco, 2001; Chin et al., 2005; 
Anand et al., 2008), while 90 to 95% of the risk factors 
are changes in reproduction patterns, lack of physical 
activity, and obesity (Jemal et al., 2011). It is expected to 
enhance the number of breast cancer cases due to changes 
in lifestyle and increased life expectancy (Mousavi et al., 
2009). 
Studies on physical activity in Iran showed that lack 
of physical activity n Iranian women, especially in older 
age groups, is more prevalent (Esteghamati et al., 2011). 
Considering that lack of physical activity is one of the risk 
factors for the cancer (Jemal et al., 2011), the cancer cases 
can be reduced through focus on the risk factor along with 
otheroperating programs.
Our findings determined a significant increasing 
incidence trend, with APC of 15.15. The greatest ASIR 
was observed in age groups of 45 to 65 years and 80 to 
85 years, respectively. The highest incidence rate breast 
cancer was seen at 40 to 49 years between1998 to 2005 in 
the country (Mousavi et al., 2007). Another study in Oman 
indicated that the highest ASIR was related to age groups 
of 45-54 years and 70-74 years, respectively (Mehdi et al., 
2014). In a study in French, 66% of female patients were 
50 to 74 years (Daubisse-Marliac et al., 2011). 
In our study, the trend of breast cancer incidence was 
increasing. The lowest and highest significant increased 
trend were related to age groups of 40 to 44 years and 
above 85 years, respectively; with APC of 12.95 and 
25.07,respectively. Results obtained from one of the 
provinces declared increased incidence rate in age groups 
of 40 to 44, 45 to 49, and 55 to 59 years, with the annual 
average increase of 6.2%, 3.5%, and 5.3%, respectively. 
There was also no difference in APC between age groups 
of 30 to 49 and 50 to 69 years (Tazhibi et al., 2014). This 
difference may be due to largeness of the region studied. 
In United States, 1990-1999, the invasive incidence breast 
cancer annually increased 1.2% and 4.8% from 1999 to 
2003, and then decreased 1.7%. However, ASIR in women 
45 years and above was decreasing between1999 to 2003. 
The lowest decrease was observed among women 55 to 59 
years (1.3%), 60 to 64 years (10.6%), and 65 to 69 years 
(14. 3%) during 2002 to 2003 (Jemal et al., 2007). This is 
opposite of our findings because a decrease in incidence 
of cases may be affected by preventive programs. 
In this study, of all cases, 78.71% of cases were 
INFILTRATING DUCT CARCINOMA, 5.37% 
LOBULAR CARCINOMA, NOS, 2.77% MEDULLARY 
CARCINOMA, NOS, and 2.71% INTRADUCTAL 
CARCINOMA, NONINFILTRATING, NOS. They 
included 89.56% of all morphologies of breast cancer 
in these women. The most common morphology 
(INFILTRATING DUCT CARCINOMA) decreased from 
81.98% in 2003 to 76.59% in 2008, which was significant 
with APC equal to -1.76. Studies performed in Iran also 
confirmed that INFILTRATING DUCT CARCINOMA is 
the most common morphology (Li et al., 2003; Mousavi 
et al., 2007; Naghibi et al., 2013). In our study, the second 
common morphology was LOBULAR CARCINOMA, 
NOS (5.61%), with APC of 3.6 showed a remarkable 
increasing trend. Other studies in Iran also stated such 
results (Mousavi et al., 2007). LOBULAR CARCINOMA, 
NOS was also the second common morphology of breast 
cancer in United States. The incidence of the morphology 
was 7.6% and increased 1.52 times from 1987 to 1999 
(Li et al., 2003). 
The main objective of breast imaging is breast cancer 
diagnosis. Mammography, as a screening test, is effective 
for early detection of the cancer (Berg et al., 2004). It 
is necessary to do regular periodic examinations and 
mammography in women, especially menopausal ages 
(Force, 2009). For detection of cancer cases, sensitivity 
of mammography reduces as breast density increases. 
In older women who have low density in their breast, 
diagnosis performs easier (Kolb et al., 2002). LOBULAR 
CARCINOMA cases are detected with lower sensitivity 
than DUCTAL CARCINOMA cases by mammography. 
Therefore, in the United States, combination of screening 
mammography, clinical examination, and MR imaging are 
used to determine the type of breast cancer (Berg et al., 
2004). An increasing trend of LOBULAR CARCINOMA, 
NOS may be due to lack of data on patients registered 
in previous years, incomplete information, or incorrect 
diagnosis. The advancement of medical diagnostic 
equipment and the use of combined detection provide 
more accurate results of morphologies of breast cancer.
There is no screening program for breast cancer in 
Iran. It is expected to increase cases with increased life 
expectancy and changes in lifestyles in the next years. 
Health policy makers in developing countries should 
consider design and implementation of the national cancer 
control program in their priority (Mousavi et al., 2009).
 The limitations of this study were the possibility of 
incomplete records or lack of information on the patients, 
and lack of patients’ information based on rural and urban 
population. A part of the increasing trend of breast cancer 
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may be due to improvements in registration and reporting 
systems during years studied. 
It seems to investigate the trend of the cancer by 
age groups in future to carry out proper screening and 
providing training to people at risk. It will help control the 
disease in the community. Knowing trend of the cancer 
and its common morphologies by provinces of the country 
can aid to reduce the incidence rate in each province using 
proper planning.
Acknowledgements 
The authors are thankful for contributions of those 
who helped them to carry out this study.
References
Almasi Z, Rafiemanesh H, Salehiniya H (2015). Epidemiology 
characteristics and trends of incidence and morphology 
of stomach cancer in Iran. Asian Pac J Cancer Prev, 16, 
2757-61.
Anand P, Kunnumakkara AB, Sundaram C, et al (2008). Cancer 
is a preventable disease that requires major lifestyle changes. 
Pharm Res, 25, 2097-116.
Berg WA, Gutierrez L, NessAiver MS, et al (2004). Diagnostic 
accuracy of mammography, clinical examination, US, and 
MR imaging in preoperative assessment of breast cancer 1. 
Radiol, 233, 830-49.
Chahine G, El Rassy E, Khazzaka A, et al (2015). Characteristics 
of incident female breast cancer in Lebanon, 1990-2013: 
Descriptive study of 612 cases from a hospital tumor registry. 
Cancer Epidemiol.
Chin TM, Tan SH, Lim SE, et al (2005). Acceptance, motivators, 
and barriers in attending breast cancer genetic counseling in 
Asians. Cancer Detect Prev, 29, 412-8.
Daubisse-Marliac L, Delafosse P, Boitard JB, et al (2011). Breast 
cancer incidence and time trend in France from 1990 to 2007: 
a population-based study from two French cancer registries. 
Ann Oncol, 22, 329-34.
Esteghamati A, Khalilzadeh O, Rashidi A, et al (2011). 
Physical activity in Iran: results of the third national 
surveillance of risk factors of non-communicable diseases 
(SuRFNCD-2007). J Physical Activity Health, 8, 27-35.
Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide 
burden of cancer in 2008: GLOBOCAN 2008. International 
J Cancer, 127, 2893-917.
Force UPST (2009). Screening for breast cancer: US Preventive 
Services Task Force recommendation statement. Ann Int 
Med, 151, 716.
Jemal A, Bray F, Center MM, et al (2011). Global cancer 
statistics. CA Cancer J Clin, 61, 69-90.
Jemal A, Center MM, DeSantis C, et al (2010). Global patterns 
of cancer incidence and mortality rates and trends. Cancer 
Epidemiology Biomarkers Prev, 19, 1893-907.
Jemal A, Ward E, Thun MJ (2007). Recent trends in breast cancer 
incidence rates by age and tumor characteristics among U.S. 
women. Breast Cancer Res, 9, R28.
Keyghobadi N, Rafiemanesh H, Mohammadian-Hafshejani 
A, et al (2015). Epidemiology and trend of cancers in the 
province of Kerman: southeast of Iran. Asian Pac J Cancer 
Prev, 16, 1409-13.
Kolb TM, Lichy J, Newhouse JH (2002). Comparison of 
the performance of screening mammography, physical 
examination, and breast us and evaluation of factors that 
influence them: an analysis of 27,825 patient evaluations 1. 
Radiol, 225, 165-75.
Li CI, Anderson BO, Daling JR, et al (2003). Trends in incidence 
rates of invasive lobular and ductal breast carcinoma. JAMA, 
289, 1421-4.
Mehdi I, Monem EA, Al Bahrani BJ, et al (2014). Age at 
diagnosis of female breast cancer in Oman: Issues and 
implications. South Asian J Cancer, 3, 101-6.
Mousavi SM, Gouya MM, Ramazani R, et al (2009). Cancer 
incidence and mortality in Iran. Ann Oncol, 20, 556-63.
Mousavi SM, Montazeri A, Mohagheghi MA, et al (2007). 
Breast cancer in Iran: an epidemiological review. Breast 
J, 13, 383-91.
Naghibi S, Shojaizadeh D, Montazeri A, et al (2013). 
Epidemiology of breast cancer in mazandaran province, 
2009-2010. J Mazandaran Univ Med Sci, 23, 113-20.
Rafiemanesh H, Mehtarpoor M, Mohammadian-Hafshejani A, 
et al (2015a). Cancer epidemiology and trends in Sistan 
and Baluchestan province, Iran. Med J Islamic Republic 
Iran, 29, 752-9.
Rafiemanesh H, Rajaei-Behbahani N, Khani Y, et al (2015b). 
Incidence trend and epidemiology of common cancers in 
the center of Iran. Global J Health Sci, 8, 146.
Razi S, Rafiemanesh H, Ghoncheh M, et al (2015). Changing 
trends of types of skin cancer in Iran. Asian Pacific J Cancer 
Prev, 16, 4955-8.
Santos SI (1999). Cancer epidemiology, principles and methods. 
Cancer epidemiology, principles and methods.
Sasco AJ (2001). Epidemiology of breast cancer: an environmental 
disease? APMIS, 109, 321-32.
Saxena S, Rekhi B, Bansal A, et al (2005). Clinico-morphological 
patterns of breast cancer including family history in a New 
Delhi hospital, India--a cross-sectional study. World J Surg 
Oncol, 3, 67.
Tazhibi M, Dehkordi ZF, Babazadeh S (2014). Trends in breast 
cancer incidence rates by age and tumor characteristics of 
women in the city of Isfahan for the period 2001-2010: An 
application of joinpoint analysis. J Res Med Sci, 19, 319-25.
Vakili M, Pirdehghan A, Adimi M, et al (2014). Epidemiology 
and trend of cancer in yazd, a central province of iran, 2005-
2009. J Res Health Sci, 14, 210-3.
WHO (2000). International classification of diseases for 
oncology: ICD-O.Geneva.
Yang L, Yuan Y, Sun T, et al (2015). Population-based cancer 
incidence analysis in Beijing, 2008-2012. Chin J Cancer 
Res, 27, 13-21.
